The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones
By Editorial Staff,
The Guardian
| 07. 05. 2026
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become increasingly urgent. There is already a worldwide legal prohibition. No country currently allows human germline editing (meaning genetic changes to an embryo that could also be passed on to its children), and 70 have laws against it, including the UK. But a series of recent discoveries and a new poll suggest that scientists and the public believe gene-edited humans are likely – even desirable – in the near future.
Two new studies use base editing – a more precise next-generation Crispr tool – on human embryos to study early development or disease (this research is legal in the UK and US as long as the embryos are destroyed within 14 days). The lead author of one study, Dieter Egli, said that the technology wasn’t yet ready for the clinic, but the advances would “guide responsible research to achieve its ultimate safe and effective use”. This encapsulates the view of many scientists, who believe the regulated use of germline...
Related Articles
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Emily Baumgaertner Nunn, The New York Times | 06.11.2026
When scientists at Columbia University announced they had used a newer technology to precisely edit the genes of human embryos last week, they set the academic community ablaze with debate. Is this good news or bad? How fast will...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...